ARTICLE | Company News

Biovail, Procyon deal

February 14, 2000 8:00 AM UTC

BVF acquired Canadian rights to PBP’s Fibrostat topical cream to treat post-operative and burn scars. BVF will pay PBP C$1.5 million (US$1 million) to complete development through Phase III, plus a C$1 million (US$67,000) milestone upon approval in Canada and royalties. ...